Healthcare Quality: Measurement and Implication Series

Access Activity

Overview / Abstract:
Quality measures continue to emerge from a variety of healthcare stakeholder groups to determine quality. Healthcare quality measures are changing the behaviors of providers, payers, and consumers. This online continuing education series provides a comprehensive overview of the healthcare quality landscape since the Affordable Care Act, including national priority setting, Advanced Alternative Payment Models (Advanced APMs), Merit-based Incentive Payment Systems (MIPS) and the complexity of quality measure development, endorsement and implementation.

A glossary, visually intuitive diagrams, and testimonials from experts in the field introduce the learner to various programs and initiatives aimed at optimizing resources, eliminating waste, and improving accountability through healthcare quality measurement. Overall this series will provide vital information for health decision-makers, providers, and organizations to align their services and products with the quality-focused healthcare marketplace. Resources in this series will keep you apprised of the MACRA Quality Payment Program changes as CMS continuously updates their approach to quality-based payments.

The Healthcare Quality: Measurement and Implications series includes two interactive, online modules representing a comprehensive introduction to the terminology, the trends, the stakeholders and leadership, and the quality improvement programs at play in the current healthcare environment. These two modules represent 3.5 hours of ACPE and ACCME certified continuing education.

Learning Objectives:
Healthcare Quality in the United States
At the end of this application-based activity, the learner should be able to:
1. Define healthcare quality;
2. Identify four (4) key stakeholders in healthcare quality and align the stakeholder with their roles in the continuous quality improvement cycle;
3. Provide accurate examples of three (3) types of quality measures;
4. Sequence the steps in quality measure development and describe quality measure evaluation criteria that leads to measure endorsement; and
5. Identify and categorize the various CMS healthcare quality improvement programs and explain how such public programs are drivers of quality in the private sector.

Quality Measurement for the Pharmaceutical Industry
At the end of this application-based activity, the learner should be able to:
1. Analyze potential implications, advantages and challenges for the pharmaceutical industry of two quality measure case examples, especially those associated with value-based payment programs;
2. Assess a measurement gap and outline proactive, appropriate steps that can be taken by the pharmaceutical industry to support healthcare quality measurement programs, especially in areas where gaps have been noted;
3. Provide two or more examples of how the implementation of new measures or changes to existing measures could have implications for a therapeutic area and possible approaches to respond to those implications;
4. Develop an engagement strategy as a solution to a challenge in quality improvement; and
5. Interpret the impact of potential changes in the landscape for healthcare quality measurement programs and anticipate strategy updates that may be needed.

CE: 3.5 Contact Hours
Universal Activity Number (UAN): 0025-0000-17-028-H04-P
Launch Date: 08/15/2017
Expiration Date: 08/15/2020
Course Number: CN#NPCS01_V2
Target Audience: Healthcare decision-makers including pharmacists, physicians, researchers, health plans, stakeholders, and industry leaders.


Aug 15, 2020


Pharmacy CPE, Physician CME





Credits / Hours




Presenters / Authors / Faculty

Eleanor Perfetto, PhD, MS, Program Director, Professor, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy

Matthew Pickering, PharmD, Program Director, Postdoctoral Fellow, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy

Activity Specialities / Related Topics

Research, Administration / Management

Sponsors / Supporters / Grant Providers

Contributors and Advisers:
Alicia DeStefano, MS, RN, CPHQ, Merck
Carol Alter, MD, AstraZeneca
Christopher Dezii, RN, MBA, CPHQ, Bristol-Myers Squibb
Nancy Witkowski, RN, BSN, CCM, CCP, Boehringer Ingelheim
Terry Livingston, PharmD, Biogen Idec
Patricia Marchlowska, RN, BSM, Lilly
Kathy Gans-Brangs, PhD, AstraZeneca
Kimberly Westrich
Jennifer Van Meter
Matthew K. Pickering
Nicole Brandt

Keywords / Search Terms

University of Maryland School of Pharmacy: CIPS Knowledge Enterprise Quality, Research, MACRA, Quality Measures, Advanced Alternative Payment Models, Advanced APM, Merit-based Incentive Payment Systems, MIPS

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.